Doximity, Inc.
DOCS
$25.33
-$0.61-2.35%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 156.62M | 145.37M | 185.05M | 168.53M | 145.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 156.62M | 145.37M | 185.05M | 168.53M | 145.91M |
| Cost of Revenue | 23.69M | 19.41M | 18.70M | 16.43M | 15.79M |
| Gross Profit | 132.93M | 125.97M | 166.35M | 152.10M | 130.12M |
| SG&A Expenses | 60.72M | 55.49M | 59.78M | 56.94M | 48.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 122.88M | 114.00M | 113.08M | 103.57M | 90.80M |
| Operating Income | 33.73M | 31.37M | 71.98M | 64.96M | 55.11M |
| Income Before Tax | 40.36M | 32.12M | 80.80M | 72.94M | 64.15M |
| Income Tax Expenses | 16.05M | 13.01M | 19.24M | 10.88M | 10.83M |
| Earnings from Continuing Operations | 24.32M | 19.11M | 61.56M | 62.06M | 53.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.32M | 19.11M | 61.56M | 62.06M | 53.32M |
| EBIT | 33.73M | 31.37M | 71.98M | 64.96M | 55.11M |
| EBITDA | 35.82M | 33.41M | 74.06M | 66.73M | 56.21M |
| EPS Basic | 0.13 | 0.10 | 0.33 | 0.33 | 0.28 |
| Normalized Basic EPS | 0.14 | 0.13 | 0.27 | 0.25 | 0.22 |
| EPS Diluted | 0.13 | 0.10 | 0.31 | 0.31 | 0.27 |
| Normalized Diluted EPS | 0.13 | 0.12 | 0.25 | 0.23 | 0.20 |
| Average Basic Shares Outstanding | 182.57M | 184.85M | 187.48M | 187.71M | 187.98M |
| Average Diluted Shares Outstanding | 191.17M | 195.03M | 199.22M | 200.75M | 201.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |